SYNCARDIA SYSTEMS, LLC

SynCardia Systems, LLC manufactures the SynCardia Total Artificial Heart (STAH), a clinically proven mechanical circulatory support device for patients with end-stage biventricular heart failure who are cardiac transplant-eligible and at imminent risk of death. The company is a wholly owned subsidiary of Picard Medical Inc. and operates from Tucson, Arizona. The STAH system comprises the implantable total artificial heart unit and two driver systems: the Companion 2 Driver System (for in-hospital and bridge-to-transplant use) and the Freedom Portable Driver System (enabling patient mobility and quality-of-life improvements). SynCardia has completed over 1,300 implants across multiple countries. The STAH is approved for sale in the U.S. and Canada and is indicated as a bridge-to-transplant therapy for patients who cannot be supported by conventional left ventricular assist devices (LVADs) alone or who require biventricular support. The company provides comprehensive clinical education, surgical technique training, patient selection guidance, and 24-hour clinical support to cardiac transplant centers and implanting surgeons. SynCardia maintains an active patient community and support program, documenting over 500 patient-years of post-implant follow-up. The device represents a critical intervention in advanced heart failure management for select patient populations.